Telemedicine for Addiction Treatment: Evidence and Implementation Strategies
The Carlat Addiction Treatment Report, Volume 8, Number 5, July 2020
Dallas Swendeman, PhD, MPH
Associate Professor, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA
Dr. Swendeman has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
As many clinicians embark on new telemedicine efforts, we review the body of literature around virtual approaches to the care of patients with addiction. Dr. Swendeman reviews the evidence of efficacy for electronic self-monitoring, text-messaging, and other strategies may support your practice, and how to implement them.